Continuing Education

PD-L1 (Programmed Death Ligand 1) as a Marker of Acute Cellular Rejection After Heart Transplantation

September 24, 2021 Editor

Circulation: Heart Failure, Ahead of Print.

← Guiding Sisyphus’s Boulder to the Top
A Primary Care Telehealth Pilot Program to Improve Access: Associations with Patients’ Health Care Utilization and Costs →